The Overt Aggression Scale in a study of lithium in aggressive conduct disorder
- PMID: 7831458
The Overt Aggression Scale in a study of lithium in aggressive conduct disorder
Abstract
This article describes an open study of lithium carbonate in conduct-disordered children. The objective of the study was to investigate the effectiveness of lithium in reducing aggression and the usefulness of the Overt Aggression Scale (OAS), as a measure of treatment effect. The subjects, 8 children, ages 9.2 to 16.9 years (mean +/- standard deviation [SD] = 12.48 +/- 2.97), were treated for 4 weeks with lithium. Optimal dosages ranged from 1200 to 1800 mg/day (mean = 1350 +/- 227) with corresponding serum lithium levels ranging from 0.86 to 1.39 mEq/L (mean = 1.05 +/- 0.17). OAS results indicated that aggression decreased significantly over time. The findings from the OAS agreed with findings from a more general measure, the Global Clinical Consensus Rating, leading to the conclusion that the OAS is a promising outcome measure for treatment studies of aggression in children. Further placebo-controlled studies of lithium carbonate in reducing aggressive behavior in conduct-disordered children, employing a specific measure such as the OAS, are warranted.
Similar articles
-
The lithium test dose prediction method in aggressive children.Psychopharmacol Bull. 1995;31(2):379-82. Psychopharmacol Bull. 1995. PMID: 7491395 Clinical Trial.
-
Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study.J Am Acad Child Adolesc Psychiatry. 1996 Apr;35(4):480-90. doi: 10.1097/00004583-199604000-00014. J Am Acad Child Adolesc Psychiatry. 1996. PMID: 8919710 Clinical Trial.
-
Placebo response in aggressive children with conduct disorder.Psychopharmacol Bull. 1994;30(2):209-13. Psychopharmacol Bull. 1994. PMID: 7831457 Clinical Trial.
-
An update on the use of lithium carbonate in aggressive children and adolescents with conduct disorder.Psychopharmacol Bull. 1995;31(1):93-102. Psychopharmacol Bull. 1995. PMID: 7675995 Review.
-
Lithium and conduct disorder.Encephale. 1993 Nov-Dec;19(6):585-90. Encephale. 1993. PMID: 12404776 Review.
Cited by
-
Pharmacological interventions for antisocial personality disorder.Cochrane Database Syst Rev. 2020 Sep 3;9(9):CD007667. doi: 10.1002/14651858.CD007667.pub3. Cochrane Database Syst Rev. 2020. PMID: 32880105 Free PMC article.
-
Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review.Curr Neuropharmacol. 2019;17(4):318-341. doi: 10.2174/1570159X16666171219142120. Curr Neuropharmacol. 2019. PMID: 29256353 Free PMC article.
-
Comparative effectiveness of holding therapy with aggressive children.Child Psychiatry Hum Dev. 1999 Summer;29(4):303-13. doi: 10.1023/a:1021349116429. Child Psychiatry Hum Dev. 1999. PMID: 10422354 Clinical Trial.
-
Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents.Psychopharmacology (Berl). 2007 Mar;191(1):127-40. doi: 10.1007/s00213-006-0537-6. Epub 2006 Sep 16. Psychopharmacology (Berl). 2007. PMID: 16983542
-
Pharmacological interventions for antisocial personality disorder.Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007667. doi: 10.1002/14651858.CD007667.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2020 Sep 3;9:CD007667. doi: 10.1002/14651858.CD007667.pub3. PMID: 20687091 Free PMC article. Updated.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical